After a year of progress, scientists say they are on the cusp of turning AI-designed antibodies into potential therapies. In ...

In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they're ...

Generative artificial intelligence is moving from the margins of pharma into the center of how new medicines are imagined, ...

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo.

The study introduces a three-circle convergence framework, AI, smart functionality and sustainability, demonstrating that the ...

The cleverer I am about miniaturizing the world, the better I am at possessing it.” That line of thinking, as practiced in nanoscale engineering, has no stronger embodiment today than ChemLex’s newly ...

As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- 1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced that its CANDID-CNS (TM) AI model has been ...

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Garden today announced BLOOM (Branching Lookup Optimized for Organic Molecules), a Markush structure search engine that gives AI drug-design teams near-instant ...

Their analysis suggests that AI-integrated microrobots are moving closer to real-world biomedical deployment, with the ...

CANDID-CNS™ is the new state-of-the-art AI model for BBB penetration: it achieves 87% AUPRC on bRo5 small molecules compared to 56% by Pfizer’s ...